Relative vaccine economics have been changing, with lower returns on investment as success rates converge with biologics
Refueling Innovation Engine Vaccines · page 22 of 40
The slide uses a bar chart to illustrate the convergence of success rates between vaccines and biologics, supporting the argument that vaccines are becoming less attractive for investment compared to biologics.
Consulting deck · industry_trends · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 list 1/1 source-note 1/1 title 1/1
Components 4
bar-grouped bullet source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 1
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.